What is Wegovy?
Wegovy is an injectable pen treatment for weight loss. When used alongside an improved diet and increased activity, it can help you steadily lose weight.
The pens contain semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that regulates your appetite by increasing feelings of fullness.
Who can use it?
Wegovy is suitable for people with a BMI of 30 or over. You can also use it if your BMI is 28 or over and you have a weight related health condition, such as diabetes and cardiovascular disease.
How do Wegovy doses work?
Wegovy comes in five different doses: 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg.
You normally start on the 0.25mg strength pen. Each Wegovy pen is usually used once a week for four weeks, before you switch to a higher dose.
You’ll continue this pattern every month until you reach the 2.4mg ‘maintenance dose’ pen.
What is the active ingredient in Wegovy?
Wegovy contains semaglutide, a medication that mimics a hormone called glucagon-like peptide 1, or GLP-1.
GLP-1 is released by your gut after you’ve eaten, and helps your body produce insulin. It can reduce your appetite by increasing feelings of fullness, and also delays gastric emptying.[1]
How does semaglutide work?
Semaglutide activates GLP-1 receptors, and replicates the actions of this hormone. Impaired GLP-1 function has been associated with obesity.[2]
By activating GLP-1 and helping it work the way it should, Wegovy can reduce hunger cues and increase satiety by telling you when you’ve had enough to eat. It can also help balance your blood sugar levels.
How often do you inject Wegovy?
You’ll use Wegovy once a week. The medication is self-administered, which means you’ll be injecting it yourself subcutaneously (under the skin). Wegovy should be applied to your thigh, abdomen or upper arm.[3]
How do I know which dose to use?
If you’ve not used Wegovy before, you’ll start on the lowest dose 0.25mg strength pen.
The different pens are color-coded, and you’ll usually move up to the next dose (and change pen color) every four weeks. The titration method of steadily increasing the amount of Wegovy gives your body time to adjust to semaglutide.
How we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.